Cargando…
Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease
BACKGROUND: Globally, the incidence and associated mortality of chronic obstructive pulmonary disease (COPD) and lung carcinoma are showing a worsening trend. There is increasing evidence that COPD is an independent risk factor for the occurrence and progression of lung carcinoma. This study aimed t...
Autores principales: | Li, Zheng, Xu, Dan, Jing, Jing, Wang, Jing, Jiang, Min, Li, Fengsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402374/ https://www.ncbi.nlm.nih.gov/pubmed/36035311 http://dx.doi.org/10.1155/2022/4254195 |
Ejemplares similares
-
Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD)
por: Jiang, Min, et al.
Publicado: (2023) -
A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome)
por: Zhen, Gao, et al.
Publicado: (2017) -
Effects of Modified Zhisou Powder on Airway Mucus Production in Chronic Obstructive Pulmonary Disease Model Rats with Cold-Dryness Syndrome
por: Zhen, Gao, et al.
Publicado: (2018) -
Traditional Chinese medicine classic herbal formula Xiaoqinglong decoction for acute exacerbation of chronic obstructive pulmonary disease: A systematic review protocol
por: Zhen, Gao, et al.
Publicado: (2018) -
Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
por: Xu, Lijuan, et al.
Publicado: (2023)